Project Details
Description
A randomised, double-blind, placebo-controlled trial with an open-label extension to assess the pharmacokinetics, safety, and efficacy of empagliflozin tablets in paediatric patients with chronic kidney disease (EMPA-KIDNEY? Kids)
| Status | Active |
|---|---|
| Effective start/end date | 5/1/25 → 4/30/36 |
Funding
- BOEHRINGER INGELHEIM VETMEDICA, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.